Liaoning Cheng Da Co., Ltd. (SHA:600739)
China
· Delayed Price · Currency is CNY 11.87
0.00 (0.00%)
Apr 29, 2026, 2:45 PM CST
Liaoning Cheng Da Revenue
In the year 2025, Liaoning Cheng Da had annual revenue of 9.90B CNY, down -12.29%. Liaoning Cheng Da had revenue of 1.79B in the quarter ending December 31, 2025, a decrease of -28.13%.
Revenue
9.90B
Revenue Growth
-8.06%
P/S Ratio
1.82
Revenue / Employee
2.99M
Employees
3,317
Market Cap
18.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.90B | -1.39B | -12.29% |
| Dec 31, 2024 | 11.29B | 506.45M | 4.70% |
| Dec 31, 2023 | 10.78B | -3.78B | -25.97% |
| Dec 31, 2022 | 14.56B | -3.81B | -20.73% |
| Dec 31, 2021 | 18.37B | 1.43B | 8.43% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Meheco Group | 35.36B |
| China National Medicines Corporation | 53.31B |
| Qingdao Baheal Medical INC. | 7.58B |
| China National Accord Medicines Corporation | 72.95B |
| Jointown Pharmaceutical Group | 164.16B |
| C.Q. Pharmaceutical Holding | 82.27B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 78.46B |
| Guangxi LiuYao Group | 20.95B |